1. Home
  2. NDRA vs ELAB Comparison

NDRA vs ELAB Comparison

Compare NDRA & ELAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NDRA
  • ELAB
  • Stock Information
  • Founded
  • NDRA 2007
  • ELAB 2020
  • Country
  • NDRA United States
  • ELAB United States
  • Employees
  • NDRA N/A
  • ELAB N/A
  • Industry
  • NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • ELAB
  • Sector
  • NDRA Health Care
  • ELAB
  • Exchange
  • NDRA Nasdaq
  • ELAB Nasdaq
  • Market Cap
  • NDRA 3.1M
  • ELAB 3.2M
  • IPO Year
  • NDRA 2017
  • ELAB 2023
  • Fundamental
  • Price
  • NDRA $4.74
  • ELAB $4.78
  • Analyst Decision
  • NDRA Strong Buy
  • ELAB
  • Analyst Count
  • NDRA 1
  • ELAB 0
  • Target Price
  • NDRA $46.00
  • ELAB N/A
  • AVG Volume (30 Days)
  • NDRA 27.1K
  • ELAB 2.4M
  • Earning Date
  • NDRA 08-14-2025
  • ELAB 08-13-2025
  • Dividend Yield
  • NDRA N/A
  • ELAB N/A
  • EPS Growth
  • NDRA N/A
  • ELAB N/A
  • EPS
  • NDRA N/A
  • ELAB N/A
  • Revenue
  • NDRA N/A
  • ELAB N/A
  • Revenue This Year
  • NDRA N/A
  • ELAB N/A
  • Revenue Next Year
  • NDRA N/A
  • ELAB N/A
  • P/E Ratio
  • NDRA N/A
  • ELAB N/A
  • Revenue Growth
  • NDRA N/A
  • ELAB N/A
  • 52 Week Low
  • NDRA $2.90
  • ELAB $4.29
  • 52 Week High
  • NDRA $22.68
  • ELAB $1,842.11
  • Technical
  • Relative Strength Index (RSI)
  • NDRA 54.47
  • ELAB 36.26
  • Support Level
  • NDRA $4.00
  • ELAB $4.29
  • Resistance Level
  • NDRA $4.69
  • ELAB $4.89
  • Average True Range (ATR)
  • NDRA 0.32
  • ELAB 0.60
  • MACD
  • NDRA 0.09
  • ELAB -0.09
  • Stochastic Oscillator
  • NDRA 100.00
  • ELAB 12.50

About NDRA ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.

About ELAB Elevai Labs Inc.

PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.

Share on Social Networks: